Benvenuto nella sezione online di

La Pediatria di Netter, 2ª ed.

Letture Consigliate

Sezione XVIII


Lisa Wray︎

Rebecca Whitmire

  • Elgarten C.W, Aplenc R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr . 2020;32(1):57–66.
  • Hijiya N, Schultz K.R, Metzler M, Millot F, Suttorp M. Pediatric chronic myeloid leukemia is a unique disease that requires a different approach. Blood . 2016;127(4):392–399.
  • Hunger S.P, Mullighan C.G. Acute lymphoblastic leukemia in children. N Engl J Med . 2015;373(16):1541–1552.
  • Raetz E.A, Teachey D.T. T-cell acute lymphoblastic leukemia. Hematology . 2016;2016(1):580–588.

Kyle B. Lenz

  • Buhtoiarov I.N. Pediatric lymphoma. Pediatr Rev . 2017;38(9):410–423. doi: 10.1542/pir.2016-0152.
  • Cairo M.S, Beishuizen A. Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol . 2019;185(6):1021–1042. doi: 10.1111/bjh.15764.
  • Hochberg J, Goldman S.C, Cairo M.S. Lymphoma. In: Kliegman R, Stanton B, St. Geme J.W, Schor N.F, Behrman R.E, Nelson W.E, eds. Nelson Textbook of Pediatrics . 21st ed. Elsevier Saunders; 2019:2656–2666 chap 523.
  • Howlader N, Noone AM, Krapcho M, et al., (eds). SEER Cancer Statistics Review, 1975–2017. Bethesda, MD: National Cancer Institute., based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
  • McCarten K.M, Nadel H.R, Shulkin B.L, et al. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma. Pediatr Radiol . 2019;49:1545–1564. doi: 10.1007/s00247-019-04529-8.

Stephanie N. Brosius, Kavita A. Desai, and Amish C. Shah

  • Barnholtz-Sloan J.S, Ostrom Q.T, Cote D. Epidemiology of brain tumors. Neurol Clin . 2018;36(3):395–419.
  • Dang M., Phillips P.C.. Pediatric brain tumors. Continuum. 2017;23(6,Neuro-oncology):1727–1757.
  • Louis D.N, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol . 2021;23(8):1231–1251.
  • Udaka Y.T, Packer R.J. Pediatric brain tumors. Neurol Clin . 2018;36(3):533–556.

Haley Newman

  • Aygun N. Biological and genetic features of neuroblastoma and their clinical importance. Curr Pediatr Rev . 2018;14(2):73–90. doi: 10.2174/1573396314666180129101627 PMID: 29380702.
  • Maris J.M. Recent advances in neuroblastoma. N Engl J Med . 2010;362(23):2202–2211. doi: 10.1056/NEJMra0804577 PMID: 20558371; PMCID: PMC3306838.
  • Matthay K.K, Maris J.M, Schleiermacher G. Neuroblastoma. Nat Rev Dis Primers . 2016;2:16078. doi: 10.1038/nrdp.2016.78 PMID: 27830764.

Ajibike Lapite

  • Ambalavanan M, Geller J.I. Treatment of advanced pediatric renal cell carcinoma. Pediatr Blood Cancer . 2019;66(8):e27766 doi: 10.1002/pbc.27766.
  • Grover S.B, Antil N, Rajani H, et al. Approach to pediatric renal tumors: an imaging review. Abdom Radiol . 2019;44(2):619–641. doi: 10.1007/s00261-018-1773-z.
  • Hutzen B, Paudel S.N, Kararoudi MN, Cassady K.A, Lee D.A, Cripe T.P. Immunotherapies for pediatric cancer: current landscape and future perspectives. Cancer Metastasis Rev . 2019;38(4):573–594. doi: 10.1007/s10555-019-09819-z.
  • Malkan A.D, Loh A, Bahrami A, et al. An approach to renal masses in pediatrics. Pediatrics . 2015;135(1):142–158. doi: 10.1542/peds.2014-1011.
  • Saltzman A.F, Carrasco A.J, Weinman J, Meyers M.L, Cost N.G. Initial imaging for pediatric renal tumors: an opportunity for improvement. J Urol . 2018;199(5):1330–1336. doi: 10.1016/j.juro.2017.11.076.
  • Walz A.L, Fernandez C.V, Geller J.I. Novel therapy for pediatric and adolescent kidney cancer. Cancer Metastasis Rev . 2019;38(4):643–655. doi: 10.1007/s10555-019-09822-4.

Timothy T. Spear, and Jenna M. Gedminas

  • Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer . 2003;97(12):3068–3075.
  • Bernstein M, Kovar H, Paulussen M, et al. Ewing sarcoma family of tumors: Ewing sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors. In: Pizzo P.A, Poplack D.G, eds. Principles and Practice of Pediatric Oncology . 5th ed. Philadelphia: Lippincott: Williams & Wilkins; 2006:1002–1032.
  • de Alava E, Gerald W.L. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol . 2000;18(1):204–213.
  • Gereige R, Kumar M. Bone lesions: benign and malignant. Pediatr Rev . 2010;31(9):355–363.
  • Grier H.E, Krailo M.D, Tarbell N.J, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med . 2003;348(8):694–701.
  • Gurney J.G, Swensen A.R, Bulterys M. Malignant bone tumors. In: Ries L.A.G, Smith M.A, Gurney J.G, et al., eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub. No 99-4649 . Bethesda, MD: National Cancer Institute, SEER Program; 1999.
  • Jackson T.M, Bittman M, Granowetter L. Pediatric malignant bone tumors: a review and update on current challenges, and emerging drug targets. Curr Probl Pediatr Adolesc Health Care . 2016;46:213–228.
  • Link M.L, Gebhardt M.C, Meyers P.A. Osteosarcoma. In: Pizzo P.A, Poplack D.G, eds. Principles and Practice of Pediatric Oncology . 5th ed. Philadelphia: Lippincott: Williams & Wilkins; 2006:1074–1115.
  • Mirabello L, Troisi R.J, Savage S.A. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer . 2009;115(7):1531–1543.

Jeremy M. Grenier, and Jenna M. Gedminas

  • Borinstein S.C, Steppan D, Hayahi M. Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer . 2018;65.
  • Hibbitts E, Chi Y.Y, Hawkins D.S. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children’s Oncology Group. Cancer Med . 2019;8:6437–6448.
  • Skapek S.X, Ferrari A, Gupta A.A. Rhabdomyosarcoma. Nat Rev Dis Primers . 2019;5:1.

Jeremy M. Grenier, and Caroline Diorio

  • Allen C.E, Beverley P.C.L, Collin M, et al. The coming of age of Langerhans cell histiocytosis. Nat Immunol . 2020;21(1):1–7.
  • Allen C.E, Merad M, McClain K.L. Langerhans-cell histiocytosis. N Engl J Med . 2018;379(9):856–868.
  • Canna S.W, Marsh R.A. Pediatric hemophagocytic lymphohistiocytosis. Blood . 2020;135(16):1332–1343.
  • Rodriguez-Galindo C, Allen C.E. Langerhans cell histiocytosis. Blood . 2020;135(16):1319–1331.